From: Risk factors for level V metastasis in patients with N1b papillary thyroid cancer
Characteristic | Value (n = 94) |
---|---|
Gender | |
Male | 26 (27.7) |
Female | 68 (72.3) |
Age (year) | 44.80 ± 13.18 |
Tumor size by USG (mm) | 16.02 ± 10.16 |
The largest size of LN by USG | 14.66 ± 7.35 |
LN/tumor size ratio by USG | 1.23 ± 0.92 |
Multi-level suspicious LNs by USG | 43 (45.7) |
Tumor location | |
Upper | 35 (37.2) |
Middle | 57 (60.6) |
Lower | 2 (2.1) |
Bilaterality | 37 (39.4) |
Extrathyroidal extension | 10 (10.6) |
Multifocality | 50 (53.2) |
Tumor size by pathology (mm) | 15.06 ± 8.12 |
The largest metastatic focus of LN by pathology (mm) | 12.98 ± 8.76 |
Metastatic focus/tumor size ratio by pathology | 1.07 ± 0.89 |
MRND | |
Right | 48 (51.1) |
Left | 36 (38.3) |
Both | 10 (10.6) |
T stage | |
TI | 70 (74.5) |
T2 | 13 (13.8) |
T3 | 11 (11.7) |
Stage | |
I | 71 (75.5) |
II | 23 (24.5) |
Recurrence | 4 (4.3) |
Follow-up period (months) | 33.44 ± 21.1 |